Literature DB >> 311786

Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.

D J McDonagh, S P Nathan, R J Knudson, M D Lebowitz.   

Abstract

For plethysmographic studies of lung mechanics and measurement of pulmonary diffusing capacity, 62 subjects were drawn from a randomly selected population sample. Data obtained from the 24 subjects of heterozygous phenotype for alpha-1-antitrypsin deficiency (PiMZ) were compared by age group with data from 38 normal (PiM) subjects matched for sex, age, and smoking history. Comparison of mean values by age group for lung volumes, diffusing capacity, lung elastic recoil, maximum expiratory flow, and the occurrence of frequency dependence of dynamic compliance revealed no differences between phenotype groups. There was no evidence of an accelerated effect of aging among PiMZ subjects when compared with normal counterparts nor was there evidence of an increased effect of smoking. From these data it appears that the PiMZ phenotype per se is not a risk factor in the development of emphysema.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311786      PMCID: PMC371953          DOI: 10.1172/JCI109303

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS.

Authors:  J MILIC-EMILI; J MEAD; J M TURNER; E M GLAUSER
Journal:  J Appl Physiol       Date:  1964-03       Impact factor: 3.531

2.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

Authors:  S ERIKSSON
Journal:  Acta Med Scand       Date:  1964-02

3.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Authors:  W S BLAKEMORE; R E FORSTER; J W MORTON; C M OGILVIE
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

4.  A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects.

Authors:  A B DUBOIS; S Y BOTELHO; G N BEDELL; R MARSHALL; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808

5.  Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men.

Authors:  C Larsson; S Eriksson; H Dirksen
Journal:  Br Med J       Date:  1977-10-08

6.  [Pulmonary abnormality and alpha 1-antitrypsin heterozygote deficiency in a working population (author's transl)].

Authors:  F Girard; F Aug; M Camara; A B Bohadana; A Bagrel; G Museur; S Abraham
Journal:  Bull Eur Physiopathol Respir       Date:  1978 Jan-Feb

7.  alpha1-Antitrypsin deficiency in nonsmokers.

Authors:  L F Black; F Kueppers
Journal:  Am Rev Respir Dis       Date:  1978-03

8.  Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.

Authors:  J O Morse; M D Lebowitz; R J Knudson; B Burrows
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

9.  Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industris.

Authors:  M Chan-Yeung; M J Ashley; P Corey; H Maledy
Journal:  Am Rev Respir Dis       Date:  1978-02

10.  Closing volume and flow volume abnormalities in alpha(1)-antitrypsin phenotype groups in a community population.

Authors:  M D Lebowitz; R J Knudson; J O Morse; D Armet
Journal:  Am Rev Respir Dis       Date:  1978-01
View more
  6 in total

Review 1.  Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

2.  Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

3.  Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).

Authors:  S F Tattersall; R P Pereira; D Hunter; G Blundell; N B Pride
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

Review 4.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

5.  Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.

Authors:  J E Gadek; J D Fulmer; J A Gelfand; M M Frank; T L Petty; R G Crystal
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

6.  Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.

Authors:  J E Gadek; H G Klein; P V Holland; R G Crystal
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.